Half year results out. Good revenue . Half year rev of $23mil compare to $24 mil for full year 2012. Loss as expected and $16 mil in the bank.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025